<?xml version="1.0" encoding="UTF-8"?>
<p>Another extensively researched herbal compound is mistletoe (
 <italic>Viscum album</italic>), a popular treatment among European oncology patients and a mainstay of anthroposophical medicine. Preclinical research has shown mistletoe to have significant ant-cancer activity, in both in vitro and in vivo settings [
 <xref rid="B14-pharmaceuticals-13-00455" ref-type="bibr">14</xref>]. In contrast to curcumin, clinical research has supported these findings, with a potential for significantly improving treatment outcomes in patients with advanced cancer. In a randomized controlled trial of 220 patients with locally advanced or metastatic pancreatic cancer, subcutaneous mistletoe injections were found to significantly increase survival rates when compared to no treatment [
 <xref rid="B15-pharmaceuticals-13-00455" ref-type="bibr">15</xref>]. However, further research is required before mistletoe injections can be incorporated into the conventional oncology treatment regimen for this purpose.
</p>
